A study led by researchers from the Clínic-IDIBAPS paves the way for the design and optimization of CAR T-cell therapy for greater effectiveness in t1
The goal of the current campaign is to reach 1,000 hours of cancer research. For each book read, 10 minutes of research, and for every six books, one1
Researchers from the Hospital Clínic-IDIBAPS have published a review in Nature Reviews Clinical Oncology about the adjuvant and neoadjuvant treatment1
The DEFINITIVE project, led by IDIBAPS, will be conducted across 44 hospitals in a total of 7 European and associated countries to demonstrate that u1
An international team, co-led by the Hospital Clínic-IDIBAPS, has identified four biomarkers that determine the risk of the recurrence of this cancer1
Endowed with €12 million, the project is coordinated by Prof. Josep M. Llovet, the head of the IDIBAPS group Translational Research in Hepatic Oncolo1
The Catalan Tumour Bank Network (XBTC) has renewed its corporate identity and website to project a more dynamic and local network in the biomedicine1
El Corte Inglés steps up its cooperation with the Spanish Association Against Cancer (AECC) by allocating one million euros over the next five years1
There are still many questions surrounding lymphoma, its differences with leukemia and, above all, its treatment.
IDIBAPS researchers have reviewed the role of fibroblasts, a type of cell found in the liver, in the progression of liver cancer, both hepatocellular1
